Risk of subsequent primary oral cancer in a cohort of 69,460 5-year survivors of childhood and adolescent cancer in Europe: the PanCareSurFup study
Background Survivors of childhood cancer are at risk of subsequent primary malignant neoplasms (SPNs), but the risk for rarer types of SPNs, such as oral cancer, is uncertain. Previous studies included few oral SPNs, hence large-scale cohorts are required to identify groups at risks. Methods The Pan...
Saved in:
| Published in | British journal of cancer Vol. 128; no. 1; pp. 80 - 90 |
|---|---|
| Main Authors | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
| Format | Journal Article |
| Language | English |
| Published |
London
Nature Publishing Group UK
2023
Nature Publishing Group Cancer Research UK |
| Subjects | |
| Online Access | Get full text |
Cover
Loading…
| Abstract | Background
Survivors of childhood cancer are at risk of subsequent primary malignant neoplasms (SPNs), but the risk for rarer types of SPNs, such as oral cancer, is uncertain. Previous studies included few oral SPNs, hence large-scale cohorts are required to identify groups at risks.
Methods
The PanCareSurFup cohort includes 69,460 5-year survivors of childhood cancer across Europe. Risks of oral SPNs were defined by standardised incidence ratios (SIRs), absolute excess risks and cumulative incidence.
Results
One hundred and forty-five oral SPNs (64 salivary gland, 38 tongue, 20 pharynx, 2 lip, and 21 other) were ascertained among 143 survivors. Survivors were at 5-fold risk of an oral SPN (95% CI: 4.4–5.6). Survivors of leukaemia were at greatest risk (SIR = 19.2; 95% CI: 14.6–25.2) followed by bone sarcoma (SIR = 6.4, 95% CI: 3.7–11.0), Hodgkin lymphoma (SIR = 6.2, 95% CI: 3.9–9.9) and soft-tissue sarcoma (SIR = 5.0, 95% CI: 3.0–8.5). Survivors treated with radiotherapy were at 33-fold risk of salivary gland SPNs (95% CI: 25.3–44.5), particularly Hodgkin lymphoma (SIR = 66.2, 95% CI: 43.6–100.5) and leukaemia (SIR = 50.5, 95% CI: 36.1–70.7) survivors. Survivors treated with chemotherapy had a substantially increased risk of a tongue SPN (SIR = 15.9, 95% CI: 10.6–23.7).
Conclusions
Previous radiotherapy increases the risk of salivary gland SPNs considerably, while chemotherapy increases the risk of tongue SPNs substantially. Awareness of these risks among both health-care professionals and survivors could play a crucial role in detecting oral SPNs early. |
|---|---|
| AbstractList | Background: Survivors of childhood cancer are at risk of subsequent primary malignant neoplasms (SPNs), but the risk for rarer types of SPNs, such as oral cancer, is uncertain. Previous studies included few oral SPNs, hence large-scale cohorts are required to identify groups at risks. Methods: The PanCareSurFup cohort includes 69,460 5-year survivors of childhood cancer across Europe. Risks of oral SPNs were defined by standardised incidence ratios (SIRs), absolute excess risks and cumulative incidence. Results: One hundred and forty-five oral SPNs (64 salivary gland, 38 tongue, 20 pharynx, 2 lip, and 21 other) were ascertained among 143 survivors. Survivors were at 5-fold risk of an oral SPN (95% CI: 4.4–5.6). Survivors of leukaemia were at greatest risk (SIR = 19.2; 95% CI: 14.6–25.2) followed by bone sarcoma (SIR = 6.4, 95% CI: 3.7–11.0), Hodgkin lymphoma (SIR = 6.2, 95% CI: 3.9–9.9) and soft-tissue sarcoma (SIR = 5.0, 95% CI: 3.0–8.5). Survivors treated with radiotherapy were at 33-fold risk of salivary gland SPNs (95% CI: 25.3–44.5), particularly Hodgkin lymphoma (SIR = 66.2, 95% CI: 43.6–100.5) and leukaemia (SIR = 50.5, 95% CI: 36.1–70.7) survivors. Survivors treated with chemotherapy had a substantially increased risk of a tongue SPN (SIR = 15.9, 95% CI: 10.6–23.7). Conclusions: Previous radiotherapy increases the risk of salivary gland SPNs considerably, while chemotherapy increases the risk of tongue SPNs substantially. Awareness of these risks among both health-care professionals and survivors could play a crucial role in detecting oral SPNs early. Abstract Background Survivors of childhood cancer are at risk of subsequent primary malignant neoplasms (SPNs), but the risk for rarer types of SPNs, such as oral cancer, is uncertain. Previous studies included few oral SPNs, hence large-scale cohorts are required to identify groups at risk s . Methods The PanCareSurFup cohort includes 69,460 5-year survivors of childhood cancer across Europe. Risks of oral SPNs were defined by standardised incidence ratios (SIRs), absolute excess risks and cumulative incidence. Results One hundred and forty-five oral SPNs (64 salivary gland, 38 tongue, 20 pharynx, 2 lip, and 21 other) were ascertained among 143 survivors. Survivors were at 5-fold risk of an oral SPN (95% CI: 4.4–5.6). Survivors of leukaemia were at greatest risk (SIR = 19.2; 95% CI: 14.6–25.2) followed by bone sarcoma (SIR = 6.4, 95% CI: 3.7–11.0), Hodgkin lymphoma (SIR = 6.2, 95% CI: 3.9–9.9) and soft-tissue sarcoma (SIR = 5.0, 95% CI: 3.0–8.5). Survivors treated with radiotherapy were at 33-fold risk of salivary gland SPNs (95% CI: 25.3–44.5), particularly Hodgkin lymphoma (SIR = 66.2, 95% CI: 43.6–100.5) and leukaemia (SIR = 50.5, 95% CI: 36.1–70.7) survivors. Survivors treated with chemotherapy had a substantially increased risk of a tongue SPN (SIR = 15.9, 95% CI: 10.6–23.7). Conclusions Previous radiotherapy increases the risk of salivary gland SPNs considerably, while chemotherapy increases the risk of tongue SPNs substantially. Awareness of these risks among both health-care professionals and survivors could play a crucial role in detecting oral SPNs early. Survivors of childhood cancer are at risk of subsequent primary malignant neoplasms (SPNs), but the risk for rarer types of SPNs, such as oral cancer, is uncertain. Previous studies included few oral SPNs, hence large-scale cohorts are required to identify groups at risks. The PanCareSurFup cohort includes 69,460 5-year survivors of childhood cancer across Europe. Risks of oral SPNs were defined by standardised incidence ratios (SIRs), absolute excess risks and cumulative incidence. One hundred and forty-five oral SPNs (64 salivary gland, 38 tongue, 20 pharynx, 2 lip, and 21 other) were ascertained among 143 survivors. Survivors were at 5-fold risk of an oral SPN (95% CI: 4.4-5.6). Survivors of leukaemia were at greatest risk (SIR = 19.2; 95% CI: 14.6-25.2) followed by bone sarcoma (SIR = 6.4, 95% CI: 3.7-11.0), Hodgkin lymphoma (SIR = 6.2, 95% CI: 3.9-9.9) and soft-tissue sarcoma (SIR = 5.0, 95% CI: 3.0-8.5). Survivors treated with radiotherapy were at 33-fold risk of salivary gland SPNs (95% CI: 25.3-44.5), particularly Hodgkin lymphoma (SIR = 66.2, 95% CI: 43.6-100.5) and leukaemia (SIR = 50.5, 95% CI: 36.1-70.7) survivors. Survivors treated with chemotherapy had a substantially increased risk of a tongue SPN (SIR = 15.9, 95% CI: 10.6-23.7). Previous radiotherapy increases the risk of salivary gland SPNs considerably, while chemotherapy increases the risk of tongue SPNs substantially. Awareness of these risks among both health-care professionals and survivors could play a crucial role in detecting oral SPNs early. Background Survivors of childhood cancer are at risk of subsequent primary malignant neoplasms (SPNs), but the risk for rarer types of SPNs, such as oral cancer, is uncertain. Previous studies included few oral SPNs, hence large-scale cohorts are required to identify groups at risks. Methods The PanCareSurFup cohort includes 69,460 5-year survivors of childhood cancer across Europe. Risks of oral SPNs were defined by standardised incidence ratios (SIRs), absolute excess risks and cumulative incidence. Results One hundred and forty-five oral SPNs (64 salivary gland, 38 tongue, 20 pharynx, 2 lip, and 21 other) were ascertained among 143 survivors. Survivors were at 5-fold risk of an oral SPN (95% CI: 4.4–5.6). Survivors of leukaemia were at greatest risk (SIR = 19.2; 95% CI: 14.6–25.2) followed by bone sarcoma (SIR = 6.4, 95% CI: 3.7–11.0), Hodgkin lymphoma (SIR = 6.2, 95% CI: 3.9–9.9) and soft-tissue sarcoma (SIR = 5.0, 95% CI: 3.0–8.5). Survivors treated with radiotherapy were at 33-fold risk of salivary gland SPNs (95% CI: 25.3–44.5), particularly Hodgkin lymphoma (SIR = 66.2, 95% CI: 43.6–100.5) and leukaemia (SIR = 50.5, 95% CI: 36.1–70.7) survivors. Survivors treated with chemotherapy had a substantially increased risk of a tongue SPN (SIR = 15.9, 95% CI: 10.6–23.7). Conclusions Previous radiotherapy increases the risk of salivary gland SPNs considerably, while chemotherapy increases the risk of tongue SPNs substantially. Awareness of these risks among both health-care professionals and survivors could play a crucial role in detecting oral SPNs early. BackgroundSurvivors of childhood cancer are at risk of subsequent primary malignant neoplasms (SPNs), but the risk for rarer types of SPNs, such as oral cancer, is uncertain. Previous studies included few oral SPNs, hence large-scale cohorts are required to identify groups at risks.MethodsThe PanCareSurFup cohort includes 69,460 5-year survivors of childhood cancer across Europe. Risks of oral SPNs were defined by standardised incidence ratios (SIRs), absolute excess risks and cumulative incidence.ResultsOne hundred and forty-five oral SPNs (64 salivary gland, 38 tongue, 20 pharynx, 2 lip, and 21 other) were ascertained among 143 survivors. Survivors were at 5-fold risk of an oral SPN (95% CI: 4.4–5.6). Survivors of leukaemia were at greatest risk (SIR = 19.2; 95% CI: 14.6–25.2) followed by bone sarcoma (SIR = 6.4, 95% CI: 3.7–11.0), Hodgkin lymphoma (SIR = 6.2, 95% CI: 3.9–9.9) and soft-tissue sarcoma (SIR = 5.0, 95% CI: 3.0–8.5). Survivors treated with radiotherapy were at 33-fold risk of salivary gland SPNs (95% CI: 25.3–44.5), particularly Hodgkin lymphoma (SIR = 66.2, 95% CI: 43.6–100.5) and leukaemia (SIR = 50.5, 95% CI: 36.1–70.7) survivors. Survivors treated with chemotherapy had a substantially increased risk of a tongue SPN (SIR = 15.9, 95% CI: 10.6–23.7).ConclusionsPrevious radiotherapy increases the risk of salivary gland SPNs considerably, while chemotherapy increases the risk of tongue SPNs substantially. Awareness of these risks among both health-care professionals and survivors could play a crucial role in detecting oral SPNs early. |
| Author | de Vathaire, Florent van der Pal, Helena J. H. Michel, Gisela Garwicz, Stanislaw Hjorth, Lars Schindera, Christina Terenziani, Monica Kaatsch, Peter Haddy, Nadia Heymer, Emma J. Bárdi, Edit Mazić, Maja Česen Gudmundsdottir, Thorgerdur Belle, Fabiën N. Maule, Milena M. Skinner, Roderick Gunnes, Maria Winther Winther, Jeanette F. Kremer, Leontien C. Sunguc, Ceren Byrne, Julianne Fresneau, Brice Ronckers, Cécile M. Bagnasco, Francesca Haupt, Riccardo Zaletel, Lorna Zadravec Reulen, Raoul C. Allodji, Rodrigue S. Jakab, Zsuzsanna Jankovic, Momcilo Grabow, Desiree Kaiser, Melanie Winter, David L. Lähteenmäki, Päivi M. Wiebe, Thomas Kuehni, Claudia E. Sacerdote, Carlotta Teepen, Jop C. Dudley, Isabelle M. Hawkins, Michael M. |
| Author_xml | – sequence: 1 givenname: Ceren orcidid: 0000-0001-7831-960X surname: Sunguc fullname: Sunguc, Ceren organization: Centre for Childhood Cancer Survivor Studies, Institute of Applied Health Research, University of Birmingham – sequence: 2 givenname: Michael M. surname: Hawkins fullname: Hawkins, Michael M. organization: Centre for Childhood Cancer Survivor Studies, Institute of Applied Health Research, University of Birmingham – sequence: 3 givenname: David L. surname: Winter fullname: Winter, David L. organization: Centre for Childhood Cancer Survivor Studies, Institute of Applied Health Research, University of Birmingham – sequence: 4 givenname: Isabelle M. surname: Dudley fullname: Dudley, Isabelle M. organization: Centre for Childhood Cancer Survivor Studies, Institute of Applied Health Research, University of Birmingham – sequence: 5 givenname: Emma J. surname: Heymer fullname: Heymer, Emma J. organization: Centre for Childhood Cancer Survivor Studies, Institute of Applied Health Research, University of Birmingham – sequence: 6 givenname: Jop C. orcidid: 0000-0002-2647-2677 surname: Teepen fullname: Teepen, Jop C. organization: Princess Máxima Center for Pediatric Oncology – sequence: 7 givenname: Rodrigue S. orcidid: 0000-0002-1895-8415 surname: Allodji fullname: Allodji, Rodrigue S. organization: Radiation Epidemiology Team, Center for Research in Epidemiology and Population Health, INSERM U1018, University Paris Saclay, Gustave Roussy – sequence: 8 givenname: Fabiën N. surname: Belle fullname: Belle, Fabiën N. organization: Childhood Cancer Research Group, Institute of Social and Preventive Medicine, University of Bern, Center for Primary Care and Public Health (Unisanté), University of Lausanne – sequence: 9 givenname: Francesca surname: Bagnasco fullname: Bagnasco, Francesca organization: IRCCS Istituto Giannina Gaslini – sequence: 10 givenname: Julianne surname: Byrne fullname: Byrne, Julianne organization: Boyne Research Institute – sequence: 11 givenname: Edit surname: Bárdi fullname: Bárdi, Edit organization: St Anna Children’s Hospital, Vienna, Austria and Department of Paediatrics and Adolescent Medicine, Johannes Kepler University Linz, Kepler University Hospital – sequence: 12 givenname: Cécile M. surname: Ronckers fullname: Ronckers, Cécile M. organization: Princess Máxima Center for Pediatric Oncology, Department of Health Services Research, Carl von Ossietzky University of Oldenburg – sequence: 13 givenname: Nadia surname: Haddy fullname: Haddy, Nadia organization: Radiation Epidemiology Team, Center for Research in Epidemiology and Population Health, INSERM U1018, University Paris Saclay, Gustave Roussy – sequence: 14 givenname: Thorgerdur surname: Gudmundsdottir fullname: Gudmundsdottir, Thorgerdur organization: Danish Cancer Society Research Center, Childhood Cancer Research Group, Children’s Hospital, Landspitali University Hospital – sequence: 15 givenname: Stanislaw surname: Garwicz fullname: Garwicz, Stanislaw organization: Department of Clinical Sciences Lund, Paediatrics, Skane University Hospital, Lund University – sequence: 16 givenname: Momcilo surname: Jankovic fullname: Jankovic, Momcilo organization: Pediatric Clinic, University of Milano-Bicocca, Hospital San Gerardo – sequence: 17 givenname: Helena J. H. surname: van der Pal fullname: van der Pal, Helena J. H. organization: Princess Máxima Center for Pediatric Oncology – sequence: 18 givenname: Maja Česen surname: Mazić fullname: Mazić, Maja Česen organization: University Children’s Hospital Ljubljana, University Medical Centre Ljubljana – sequence: 19 givenname: Christina surname: Schindera fullname: Schindera, Christina organization: Childhood Cancer Research Group, Institute of Social and Preventive Medicine, University of Bern, Division of Pediatric Oncology/Haematology, University Children’s Hospital Basel, University of Basel – sequence: 20 givenname: Desiree surname: Grabow fullname: Grabow, Desiree organization: German Childhood Cancer Registry, Division of Childhood Cancer Epidemiology, Institute of Medical Biostatistics, Epidemiology and Informatics (IMBEI), Johannes-Gutenberg University Mainz – sequence: 21 givenname: Milena M. orcidid: 0000-0003-2142-1288 surname: Maule fullname: Maule, Milena M. organization: Childhood Cancer Registry of Piedmont, Cancer Epidemiology Unit, Department of Medical Sciences, University of Turin and CPO-Piemonte, AOU Città della Salute e della Scienza di Torino – sequence: 22 givenname: Peter surname: Kaatsch fullname: Kaatsch, Peter organization: German Childhood Cancer Registry, Division of Childhood Cancer Epidemiology, Institute of Medical Biostatistics, Epidemiology and Informatics (IMBEI), Johannes-Gutenberg University Mainz – sequence: 23 givenname: Melanie surname: Kaiser fullname: Kaiser, Melanie organization: German Childhood Cancer Registry, Division of Childhood Cancer Epidemiology, Institute of Medical Biostatistics, Epidemiology and Informatics (IMBEI), Johannes-Gutenberg University Mainz – sequence: 24 givenname: Brice orcidid: 0000-0001-7603-7828 surname: Fresneau fullname: Fresneau, Brice organization: Radiation Epidemiology Team, Center for Research in Epidemiology and Population Health, INSERM U1018, University Paris Saclay, Gustave Roussy, Department of Children and Adolescents Oncology, Gustave Roussy – sequence: 25 givenname: Gisela orcidid: 0000-0002-9589-0928 surname: Michel fullname: Michel, Gisela organization: Department of Health Sciences and Medicine, University of Lucerne – sequence: 26 givenname: Roderick surname: Skinner fullname: Skinner, Roderick organization: Great North Children’s Hospital, Newcastle upon Tyne Hospitals NHS Foundation Trust, and Newcastle University Centre for Cancer, Newcastle University – sequence: 27 givenname: Thomas surname: Wiebe fullname: Wiebe, Thomas organization: Department of Clinical Sciences Lund, Paediatrics, Skane University Hospital, Lund University – sequence: 28 givenname: Carlotta surname: Sacerdote fullname: Sacerdote, Carlotta organization: Childhood Cancer Registry of Piedmont, Cancer Epidemiology Unit, Department of Medical Sciences, University of Turin and CPO-Piemonte, AOU Città della Salute e della Scienza di Torino – sequence: 29 givenname: Zsuzsanna surname: Jakab fullname: Jakab, Zsuzsanna organization: Hungarian Childhood Cancer Registry, 2nd Department of Pediatrics, Semmelweis University – sequence: 30 givenname: Maria Winther surname: Gunnes fullname: Gunnes, Maria Winther organization: Division of Paediatric and Adolescent Medicine, Oslo University Hospital Rikshospitalet, Department of Registration, Cancer Registry of Norway – sequence: 31 givenname: Monica surname: Terenziani fullname: Terenziani, Monica organization: Pediatric Oncology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori – sequence: 32 givenname: Jeanette F. orcidid: 0000-0002-3440-5108 surname: Winther fullname: Winther, Jeanette F. organization: Danish Cancer Society Research Center, Childhood Cancer Research Group, Department of Clinical Medicine, Faculty of Health, Aarhus University and University Hospital – sequence: 33 givenname: Päivi M. orcidid: 0000-0002-5500-9606 surname: Lähteenmäki fullname: Lähteenmäki, Päivi M. organization: Department of Pediatrics and Adolescent Medicine, Turku University and Turku University Hospital – sequence: 34 givenname: Lorna Zadravec surname: Zaletel fullname: Zaletel, Lorna Zadravec organization: Division of Radiotherapy, Institute of Oncology – sequence: 35 givenname: Claudia E. surname: Kuehni fullname: Kuehni, Claudia E. organization: Childhood Cancer Research Group, Institute of Social and Preventive Medicine, University of Bern, Division of Pediatric Hematology/Oncology, Department of Paediatrics, University Children’s Hospital of Bern, University of Bern – sequence: 36 givenname: Leontien C. surname: Kremer fullname: Kremer, Leontien C. organization: Princess Máxima Center for Pediatric Oncology, Emma Children’s Hospital Amsterdam UMC, location University of Amsterdam, Department of Pediatrics – sequence: 37 givenname: Riccardo surname: Haupt fullname: Haupt, Riccardo organization: DOPO clinic, Division of Hematology/Oncology, IRCCS Istituto Giannina Gaslini – sequence: 38 givenname: Florent surname: de Vathaire fullname: de Vathaire, Florent organization: Radiation Epidemiology Team, Center for Research in Epidemiology and Population Health, INSERM U1018, University Paris Saclay, Gustave Roussy – sequence: 39 givenname: Lars surname: Hjorth fullname: Hjorth, Lars organization: Department of Clinical Sciences Lund, Paediatrics, Skane University Hospital, Lund University – sequence: 40 givenname: Raoul C. orcidid: 0000-0002-7328-0467 surname: Reulen fullname: Reulen, Raoul C. email: r.c.reulen@bham.ac.uk organization: Centre for Childhood Cancer Survivor Studies, Institute of Applied Health Research, University of Birmingham |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/36319851$$D View this record in MEDLINE/PubMed https://hal.science/hal-04122356$$DView record in HAL https://lup.lub.lu.se/record/640a2d4a-ad47-4dbe-90ae-e6ea0d04659a$$DView record from Swedish Publication Index |
| BookMark | eNp9kstu1DAUhi1URKeFF2CBLLFCIuBbHJsFUjVqKdJIIC5ry4mPm5RpPLWTGc1z8MI4ZGgpCxZHuZz__6xz_J-goz70gNBzSt5QwtXbJKigsiCM5SL5bfcILWjJWUEVq47QghBSFUQzcoxOUrrOn5qo6gk65pJTrUq6QD-_dOkHDh6nsU5wO0I_4E3sbmzc4xDtGje2byDirscWN6ENcZjUUr8WkuCy2ION2Ru33TbENLWatlu7NgSHbZ_LhTWkZsLek87HGDbwDg8t4M-2X9oIX8d4MW5wGka3f4oee7tO8OzwPEXfL86_LS-L1acPH5dnq6Ipq2ooZCU8B6FczRrXVGXFpPbCK-JBMu2JFLTUztcKdMl5tjjFee0bBkCU9YSfotXMTTvYjLU5zG2C7cx63OSqc5kERgpimRPWWCcqI1wNRhMLBiRY4oiQpbYZ937GZdYNuGnmvMAH1IedvmvNVdgarajgWmXAqxnQ_mO7PFuZ6R8RlDFeyi3N2peHw2LIt5YGcx3G2Od1GVZJmi9eEZ1VbFY1MaQUwd9hKTFThsycIZMzZH5nyOyy6cXfc9xZ_oQmC_hhb7nVX0G8P_s_2F_x7NWQ |
| CitedBy_id | crossref_primary_10_3390_dj12010017 |
| Cites_doi | 10.1016/j.ejca.2014.01.027 10.1186/1758-3284-4-20 10.1056/NEJMsa060185 10.1002/cncr.20910 10.1016/j.ejca.2014.10.016 10.1016/j.ijrobp.2012.06.006 10.1667/RR15386.1 10.7326/0003-4819-131-10-199911160-00004 10.1002/ijc.22827 10.1093/jnci/80.12.943 10.1056/NEJM199703273361301 10.1186/1758-3284-1-29 10.1016/j.ejca.2017.05.026 10.1007/s10654-018-0370-3 10.1016/j.ejca.2018.08.017 10.1002/(SICI)1097-0258(19990330)18:6<695::AID-SIM60>3.0.CO;2-O 10.1007/s00520-014-2260-x 10.1001/jama.2011.747 10.1016/S1470-2045(18)30903-3 10.1038/nrc722 10.1016/j.ejca.2021.06.004 10.1093/jnci/djx165 10.1016/j.oraloncology.2017.07.014 10.1002/(SICI)1097-0142(19970415)79:8<1465::AID-CNCR4>3.0.CO;2-A 10.18632/oncotarget.25540 10.1002/pbc.27668 10.1093/jnci/djn210 10.2307/3579909 10.1093/jnci/djx235 10.1016/S1470-2045(13)70548-5 10.1200/JCO.2005.02.7235 10.1093/jnci/92.9.709 10.1001/archotol.129.1.106 10.1016/j.oraloncology.2013.07.003 10.1136/gutjnl-2020-322237 |
| ContentType | Journal Article |
| Copyright | The Author(s) 2022 2022. The Author(s). The Author(s) 2022. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. Distributed under a Creative Commons Attribution 4.0 International License |
| Copyright_xml | – notice: The Author(s) 2022 – notice: 2022. The Author(s). – notice: The Author(s) 2022. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. – notice: Distributed under a Creative Commons Attribution 4.0 International License |
| DBID | C6C CGR CUY CVF ECM EIF NPM AAYXX CITATION 3V. 7RV 7TO 7U9 7X7 7XB 88E 8AO 8C1 8FE 8FH 8FI 8FJ 8FK ABUWG AFKRA AN0 AZQEC BBNVY BENPR BHPHI CCPQU DWQXO FYUFA GHDGH GNUQQ H94 HCIFZ K9. KB0 LK8 M0S M1P M7P NAPCQ PQEST PQQKQ PQUKI PRINS 1XC VOOES 5PM ADTPV AGCHP AOWAS D8T D95 ZZAVC |
| DOI | 10.1038/s41416-022-02016-w |
| DatabaseName | Springer_OA刊 Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef ProQuest Central (Corporate) Nursing & Allied Health Database Oncogenes and Growth Factors Abstracts Virology and AIDS Abstracts Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) ProQuest Pharma Collection Public Health Database ProQuest SciTech Collection ProQuest Natural Science Collection Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland British Nursing Database ProQuest Central Essentials Biological Science Collection ProQuest Central Natural Science Collection ProQuest One Community College ProQuest Central Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student AIDS and Cancer Research Abstracts SciTech Premium Collection ProQuest Health & Medical Complete (Alumni) Nursing & Allied Health Database (Alumni Edition) Biological Sciences Health & Medical Collection (Alumni Edition) PML(ProQuest Medical Library) Biological Science Database Nursing & Allied Health Premium ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China Hyper Article en Ligne (HAL) Hyper Article en Ligne (HAL) (Open Access) PubMed Central (Full Participant titles) SwePub SWEPUB Lunds universitet full text SwePub Articles SWEPUB Freely available online SWEPUB Lunds universitet SwePub Articles full text |
| DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef ProQuest Central Student Oncogenes and Growth Factors Abstracts ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) SciTech Premium Collection ProQuest One Community College ProQuest Natural Science Collection ProQuest Pharma Collection ProQuest Central China ProQuest Central Health Research Premium Collection Health and Medicine Complete (Alumni Edition) Natural Science Collection ProQuest Central Korea Biological Science Collection AIDS and Cancer Research Abstracts ProQuest Medical Library (Alumni) ProQuest Public Health Virology and AIDS Abstracts ProQuest Biological Science Collection ProQuest One Academic Eastern Edition British Nursing Index with Full Text ProQuest Nursing & Allied Health Source ProQuest Hospital Collection Health Research Premium Collection (Alumni) Biological Science Database ProQuest SciTech Collection ProQuest Hospital Collection (Alumni) Nursing & Allied Health Premium ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition ProQuest Nursing & Allied Health Source (Alumni) ProQuest One Academic ProQuest Central (Alumni) |
| DatabaseTitleList | CrossRef MEDLINE ProQuest Central Student |
| Database_xml | – sequence: 1 dbid: C6C name: SpringerOpen url: http://www.springeropen.com/ sourceTypes: Publisher – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 4 dbid: BENPR name: AUTh Library subscriptions: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 1532-1827 |
| EndPage | 90 |
| ExternalDocumentID | oai_lup_lub_lu_se_640a2d4a_ad47_4dbe_90ae_e6ea0d04659a oai_HAL_hal_04122356v1 10_1038_s41416_022_02016_w 36319851 |
| Genre | Research Support, Non-U.S. Gov't Journal Article |
| GeographicLocations | Europe |
| GeographicLocations_xml | – name: Europe |
| GrantInformation_xml | – fundername: The PanCareSurFup consortium and related work was supported by the European Union’s Seventh Framework Programme for research, technological development and demonstration under grant agreement no. 257505. Additional financial support was received from: The Foundation Force de recherche sur le cancer de l’enfant (FORCE), The Italian Association for Cancer Research and the Compagnia San Paolo; The Fondo Chiara Rama ONLUS; The Swedish Childhood Cancer Fund; the French Association for Cancer Research (ARC); The French National Agency for Research (ANR) (Hope-Epi project); the French National Cancer Institute (INCA); Pfizer Foundation for Children and Adolescent Health; Slovenian Research Agency; the Swiss Paediatric Oncology Group; The Swiss Cancer League (KLS-3412-02-2014, KLS-3886-02-2016, KLS-5432-08-2021); The Swiss Cancer Research foundation (KFS-02783-02-2011, KFS-4157-02-2017, KLA/KFS-4825-01-2019, KFS-4722-02-2019, KFS-5302-02-2021); The Swiss National Science Foundation (PDFMP3_141775), The Dutch Cancer Society (DCOG2011-5027 and UVA2012-5517), The Norwegian Childhood Cancer Foundation, and Children with Cancer UK (grant no: 20457). CS was supported by a studentship from the Turkish Ministry of National Education. – fundername: ; |
| GroupedDBID | --- 0R~ 23N 36B 39C 4.4 406 53G 5GY 5RE 6J9 70F 7RV 7X7 88E 8AO 8C1 8FI 8FJ 8R4 8R5 AACDK AANZL AASML AATNV AAWBL AAWTL AAZLF ABAKF ABLJU ABOCM ABUWG ABZZP ACAOD ACGFO ACGFS ACKTT ACPRK ACRQY ACZOJ ADBBV ADFRT ADHDB AEFQL AEJRE AEMSY AENEX AEVLU AEXYK AFBBN AFKRA AFRAH AFSHS AGAYW AGEZK AGHAI AGQEE AHMBA AHSBF AIGIU AILAN AJRNO ALFFA ALMA_UNASSIGNED_HOLDINGS AMYLF AN0 AOIJS ASPBG AVWKF AXYYD AZFZN BAWUL BBNVY BENPR BHPHI BKEYQ BKKNO BNQBC BPHCQ BVXVI C6C CCPQU CS3 DIK DNIVK DPUIP DU5 E3Z EAP EBLON EBS EE. EIOEI EMB ESX EX3 F5P FDQFY FEDTE FERAY FIGPU FRJ FSGXE FYUFA GX1 HCIFZ HMCUK HVGLF HYE HZ~ IH2 IWAJR JSO JZLTJ KQ8 M1P M7P NAPCQ NQJWS O9- OK1 P2P PQQKQ PROAC PSQYO Q2X RNT RNTTT RPM SNX SNYQT SOHCF SRMVM SWTZT TAOOD TBHMF TDRGL TR2 UKHRP W2D WH7 WOW ~02 -Q- .55 .GJ 3V. 8WZ A6W AAYZH ABAWZ ABDBF AI. B0M CAG CGR COF CUY CVF EAD EAS EBC EBD ECM EIF EJD EMK EMOBN EPL FIZPM J5H M41 NAO NPM SV3 TUS UDS VH1 X7M Y6R ZGI ~8M AAYXX CITATION 7TO 7U9 7XB 8FE 8FH 8FK AZQEC DWQXO GNUQQ H94 K9. LK8 PQEST PQUKI PRINS 1XC VOOES 5PM ADTPV AGCHP AOWAS D8T D95 ZZAVC |
| ID | FETCH-LOGICAL-c577t-674f3e48db2cdc757269f4f80fe629f064159dfb8e9533577d833bfc2ee08af03 |
| IEDL.DBID | RPM |
| ISSN | 0007-0920 |
| IngestDate | Sat Oct 19 03:44:17 EDT 2024 Tue Sep 17 21:30:11 EDT 2024 Tue Oct 15 16:00:17 EDT 2024 Thu Oct 10 16:24:55 EDT 2024 Thu Sep 26 17:29:31 EDT 2024 Wed Oct 16 00:40:45 EDT 2024 Fri Oct 11 20:37:32 EDT 2024 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 1 |
| Language | English |
| License | 2022. The Author(s). Distributed under a Creative Commons Attribution 4.0 International License: http://creativecommons.org/licenses/by/4.0 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c577t-674f3e48db2cdc757269f4f80fe629f064159dfb8e9533577d833bfc2ee08af03 |
| Notes | PMCID: PMC9814398 |
| ORCID | 0000-0001-7831-960X 0000-0002-3440-5108 0000-0003-2142-1288 0000-0002-1895-8415 0000-0002-2647-2677 0000-0002-9589-0928 0000-0002-7328-0467 0000-0002-5500-9606 0000-0001-7603-7828 0000-0002-4423-0276 0000-0001-8957-2002 0000-0002-7080-6718 0000-0002-7619-7845 0000-0003-3524-4657 0000-0003-1601-9518 0000-0003-0571-8460 0000-0002-8008-5096 0000-0002-8374-9281 |
| OpenAccessLink | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9814398/ |
| PMID | 36319851 |
| PQID | 2761007809 |
| PQPubID | 41855 |
| PageCount | 11 |
| ParticipantIDs | swepub_primary_oai_lup_lub_lu_se_640a2d4a_ad47_4dbe_90ae_e6ea0d04659a pubmedcentral_primary_oai_pubmedcentral_nih_gov_9814398 hal_primary_oai_HAL_hal_04122356v1 proquest_journals_2761007809 crossref_primary_10_1038_s41416_022_02016_w pubmed_primary_36319851 springer_journals_10_1038_s41416_022_02016_w |
| PublicationCentury | 2000 |
| PublicationDate | 2023 |
| PublicationDateYYYYMMDD | 2023-01-01 |
| PublicationDate_xml | – year: 2023 text: 2023 |
| PublicationDecade | 2020 |
| PublicationPlace | London |
| PublicationPlace_xml | – name: London – name: England |
| PublicationTitle | British journal of cancer |
| PublicationTitleAbbrev | Br J Cancer |
| PublicationTitleAlternate | Br J Cancer |
| PublicationYear | 2023 |
| Publisher | Nature Publishing Group UK Nature Publishing Group Cancer Research UK |
| Publisher_xml | – name: Nature Publishing Group UK – name: Nature Publishing Group – name: Cancer Research UK |
| References | Goertzen, Mahdi, Laliberte, Meirson, Eymael, Gil-Henn (CR33) 2018; 9 Kruse, Grätz (CR35) 2009; 1 Oeffinger, Mertens, Sklar, Kawashima, Hudson, Meadows (CR4) 2006; 355 Grabow, Kaiser, Hjorth, Byrne, Alessi, Allodji (CR1) 2018; 33 van Kalsbeek, van der Pal, Kremer, Bardi, Brown, Effeney (CR37) 2021; 154 Fidler, Reulen, Winter, Allodji, Bagnasco, Bárdi (CR16) 2018; 110 Feller, Altini, Lemmer (CR34) 2013; 49 CR18 Kolb, Socié, Duell, Van Lint, Tichelli, Apperley (CR29) 1999; 131 Bhatia, Sklar (CR9) 2002; 2 Moon, Moon, Wang, Weissler, Hackman, Zanation (CR11) 2017; 72 Steliarova-Foucher, O’Callaghan, Ferlay, Masuyer, Rosso, Forman (CR22) 2015; 51 Saku, Hayashi, Takahara, Matsuura, Tokunaga, Tokunaga (CR24) 1997; 79 Curtis, Rowlings, Deeg, Shriner, Socié, Travis (CR30) 1997; 336 Bright, Reulen, Winter, Stark, McCabe, Edgar (CR8) 2019; 20 Bright, Hawkins, Winter, Alessi, Allodji, Bagnasco (CR17) 2018; 110 Inskip, Curtis (CR14) 2007; 121 Gillison (CR31) 2000; 92 Bassal, Mertens, Taylor, Neglia, Greffe, Hammond (CR12) 2006; 24 Hussein, Helder, de Visscher, Leemans, Braakhuis, de Vet (CR13) 2017; 82 Näsman, Nordfors, Holzhauser, Vlastos, Tertipis, Hammar (CR32) 2015; 51 CR6 Steliarova-Foucher, Stiller, Lacour, Kaatsch (CR19) 2005; 103 Effinger, Migliorati, Hudson, McMullen, Kaste, Ruble (CR10) 2014; 22 Gooley, Leisenring, Crowley, Storer (CR23) 1999; 18 Sakata, Preston, Brenner, Sugiyama, Grant, Rajaraman (CR26) 2019; 192 Schneider, Lubin, Ron, Abrahams, Stovall, Goel (CR27) 1998; 149 Reulen, Frobisher, Winter, Kelly, Lancashire, Stiller (CR5) 2011; 305 CR21 CR20 Boukheris, Stovall, Gilbert, Stratton, Smith, Weathers (CR15) 2013; 85 Preston-Martin, Thomas, White, Cohen (CR25) 1988; 80 Credé, Locher, Bredell (CR28) 2012; 4 Gatta, Botta, Rossi, Aareleid, Bielska-Lasota, Clavel (CR2) 2014; 15 Byrne, Alessi, Allodji, Bagnasco, Bárdi, Bautz (CR3) 2018; 103 Fidler, Frobisher, Hawkins, Nathan (CR7) 2019; 66 Frobisher, Winter, Lancashire, Reulen, Taylor, Eiser (CR38) 2008; 100 Kutler, Auerbach, Satagopan, Giampietro, Batish, Huvos (CR36) 2003; 129 KC Oeffinger (2016_CR4) 2006; 355 E Steliarova-Foucher (2016_CR19) 2005; 103 AB Schneider (2016_CR27) 1998; 149 RJ van Kalsbeek (2016_CR37) 2021; 154 L Feller (2016_CR34) 2013; 49 KE Effinger (2016_CR10) 2014; 22 DH Moon (2016_CR11) 2017; 72 C Goertzen (2016_CR33) 2018; 9 RE Curtis (2016_CR30) 1997; 336 A Credé (2016_CR28) 2012; 4 CJ Bright (2016_CR17) 2018; 110 E Steliarova-Foucher (2016_CR22) 2015; 51 H Boukheris (2016_CR15) 2013; 85 S Preston-Martin (2016_CR25) 1988; 80 A Näsman (2016_CR32) 2015; 51 D Grabow (2016_CR1) 2018; 33 2016_CR18 C Frobisher (2016_CR38) 2008; 100 DI Kutler (2016_CR36) 2003; 129 PD Inskip (2016_CR14) 2007; 121 2016_CR6 MM Fidler (2016_CR7) 2019; 66 MM Fidler (2016_CR16) 2018; 110 ML Gillison (2016_CR31) 2000; 92 R Sakata (2016_CR26) 2019; 192 M Bassal (2016_CR12) 2006; 24 2016_CR21 HJ Kolb (2016_CR29) 1999; 131 2016_CR20 J Byrne (2016_CR3) 2018; 103 AA Hussein (2016_CR13) 2017; 82 S Bhatia (2016_CR9) 2002; 2 CJ Bright (2016_CR8) 2019; 20 AL Kruse (2016_CR35) 2009; 1 RC Reulen (2016_CR5) 2011; 305 G Gatta (2016_CR2) 2014; 15 TA Gooley (2016_CR23) 1999; 18 T Saku (2016_CR24) 1997; 79 |
| References_xml | – ident: CR18 – volume: 51 start-page: 1131 year: 2015 end-page: 43 ident: CR22 article-title: The European Cancer Observatory: a new data resource publication-title: Eur J Cancer doi: 10.1016/j.ejca.2014.01.027 contributor: fullname: Forman – volume: 4 start-page: 20 year: 2012 ident: CR28 article-title: Tongue cancer in young patients: case report of a 26-year-old patient publication-title: Head Neck Oncol doi: 10.1186/1758-3284-4-20 contributor: fullname: Bredell – volume: 355 start-page: 1572 year: 2006 end-page: 82 ident: CR4 article-title: Chronic health conditions in adult survivors of childhood cancer publication-title: N Engl J Med doi: 10.1056/NEJMsa060185 contributor: fullname: Meadows – volume: 103 start-page: 1457 year: 2005 end-page: 67 ident: CR19 article-title: International Classification of Childhood Cancer, third edition publication-title: Cancer. doi: 10.1002/cncr.20910 contributor: fullname: Kaatsch – volume: 51 start-page: 55 year: 2015 end-page: 61 ident: CR32 article-title: Incidence of human papillomavirus positive tonsillar and base of tongue carcinoma: a stabilisation of an epidemic of viral induced carcinoma? publication-title: Eur J Cancer doi: 10.1016/j.ejca.2014.10.016 contributor: fullname: Hammar – volume: 85 start-page: 776 year: 2013 end-page: 83 ident: CR15 article-title: Risk of salivary gland cancer after childhood cancer: a report from the Childhood Cancer Survivor Study publication-title: Int J Radiat Oncol Biol Phys doi: 10.1016/j.ijrobp.2012.06.006 contributor: fullname: Weathers – volume: 192 start-page: 331 year: 2019 ident: CR26 article-title: Radiation-related risk of cancers of the upper digestive tract among japanese atomic bomb survivors publication-title: Radiat Res doi: 10.1667/RR15386.1 contributor: fullname: Rajaraman – volume: 131 start-page: 738 year: 1999 end-page: 44 ident: CR29 article-title: Malignant neoplasms in long-term survivors of bone marrow transplantation publication-title: Ann Intern Med doi: 10.7326/0003-4819-131-10-199911160-00004 contributor: fullname: Apperley – volume: 121 start-page: 2233 year: 2007 end-page: 40 ident: CR14 article-title: New malignancies following childhood cancer in the United States, 1973–2002 publication-title: Int J Cancer doi: 10.1002/ijc.22827 contributor: fullname: Curtis – volume: 80 start-page: 943 year: 1988 end-page: 9 ident: CR25 article-title: Prior exposure to medical and dental X-rays related to tumors of the parotid gland publication-title: J Natl Cancer Inst doi: 10.1093/jnci/80.12.943 contributor: fullname: Cohen – ident: CR6 – volume: 336 start-page: 897 year: 1997 end-page: 904 ident: CR30 article-title: Solid cancers after bone marrow transplantation publication-title: N Engl J Med doi: 10.1056/NEJM199703273361301 contributor: fullname: Travis – volume: 1 start-page: 29 year: 2009 ident: CR35 article-title: Oral carcinoma after hematopoietic stem cell transplantation – a new classification based on a literature review over 30 years publication-title: Head Neck Oncol doi: 10.1186/1758-3284-1-29 contributor: fullname: Grätz – volume: 82 start-page: 115 year: 2017 end-page: 27 ident: CR13 article-title: Global incidence of oral and oropharynx cancer in patients younger than 45 years versus older patients: a systematic review publication-title: Eur J Cancer doi: 10.1016/j.ejca.2017.05.026 contributor: fullname: de Vet – volume: 33 start-page: 335 year: 2018 end-page: 49 ident: CR1 article-title: The PanCareSurFup cohort of 83,333 five-year survivors of childhood cancer: a cohort from 12 European countries publication-title: Eur J Epidemiol doi: 10.1007/s10654-018-0370-3 contributor: fullname: Allodji – volume: 103 start-page: 238 year: 2018 end-page: 48 ident: CR3 article-title: The PanCareSurFup consortium: research and guidelines to improve lives for survivors of childhood cancer publication-title: Eur J Cancer doi: 10.1016/j.ejca.2018.08.017 contributor: fullname: Bautz – volume: 18 start-page: 695 year: 1999 end-page: 706 ident: CR23 article-title: Estimation of failure probabilities in the presence of competing risks: new representations of old estimators publication-title: Stat Med doi: 10.1002/(SICI)1097-0258(19990330)18:6<695::AID-SIM60>3.0.CO;2-O contributor: fullname: Storer – volume: 22 start-page: 2009 year: 2014 end-page: 19 ident: CR10 article-title: Oral and dental late effects in survivors of childhood cancer: a Children’s Oncology Group report publication-title: Support Care Cancer doi: 10.1007/s00520-014-2260-x contributor: fullname: Ruble – volume: 305 start-page: 2311 year: 2011 end-page: 9 ident: CR5 article-title: Long-term risks of subsequent primary neoplasms among survivors of childhood cancer publication-title: JAMA. doi: 10.1001/jama.2011.747 contributor: fullname: Stiller – ident: CR21 – volume: 20 start-page: 531 year: 2019 end-page: 45 ident: CR8 article-title: Risk of subsequent primary neoplasms in survivors of adolescent and young adult cancer (Teenage and Young Adult Cancer Survivor Study): a population-based, cohort study publication-title: Lancet Oncol doi: 10.1016/S1470-2045(18)30903-3 contributor: fullname: Edgar – volume: 2 start-page: 124 year: 2002 end-page: 32 ident: CR9 article-title: Second cancers in survivors of childhood cancer publication-title: Nat Rev Cancer doi: 10.1038/nrc722 contributor: fullname: Sklar – volume: 154 start-page: 316 year: 2021 end-page: 28 ident: CR37 article-title: European PanCareFollowUp recommendations for surveillance of late effects of childhood, adolescent, and young adult cancer publication-title: Eur J Cancer doi: 10.1016/j.ejca.2021.06.004 contributor: fullname: Effeney – volume: 110 start-page: 183 year: 2018 end-page: 94 ident: CR16 article-title: Risk of subsequent bone cancers among 69 460 five-year survivors of childhood and adolescent cancer in Europe publication-title: J Natl Cancer Inst doi: 10.1093/jnci/djx165 contributor: fullname: Bárdi – volume: 72 start-page: 98 year: 2017 end-page: 103 ident: CR11 article-title: Incidence of, and risk factors for, mandibular osteoradionecrosis in patients with oral cavity and oropharynx cancers publication-title: Oral Oncol doi: 10.1016/j.oraloncology.2017.07.014 contributor: fullname: Zanation – volume: 79 start-page: 1465 year: 1997 end-page: 75 ident: CR24 article-title: Salivary gland tumors among atomic bomb survivors, 1950-1987 publication-title: Cancer. doi: 10.1002/(SICI)1097-0142(19970415)79:8<1465::AID-CNCR4>3.0.CO;2-A contributor: fullname: Tokunaga – volume: 9 start-page: 29047 year: 2018 end-page: 63 ident: CR33 article-title: Oral inflammation promotes oral squamous cell carcinoma invasion publication-title: Oncotarget. doi: 10.18632/oncotarget.25540 contributor: fullname: Gil-Henn – volume: 66 start-page: e27668 year: 2019 ident: CR7 article-title: Challenges and opportunities in the care of survivors of adolescent and young adult cancers publication-title: Pediatr Blood Cancer doi: 10.1002/pbc.27668 contributor: fullname: Nathan – volume: 100 start-page: 1068 year: 2008 end-page: 81 ident: CR38 article-title: Extent of smoking and age at initiation of smoking among adult survivors of childhood cancer in Britain publication-title: J Natl Cancer Inst doi: 10.1093/jnci/djn210 contributor: fullname: Eiser – volume: 149 start-page: 625 year: 1998 end-page: 30 ident: CR27 article-title: Salivary gland tumors after childhood radiation treatment for benign conditions of the head and neck: dose-response relationships publication-title: Radiat Res doi: 10.2307/3579909 contributor: fullname: Goel – volume: 110 start-page: 649 year: 2018 end-page: 60 ident: CR17 article-title: Risk of soft-tissue sarcoma among 69 460 five-year survivors of childhood cancer in Europe publication-title: J Natl Cancer Inst doi: 10.1093/jnci/djx235 contributor: fullname: Bagnasco – volume: 15 start-page: 35 year: 2014 end-page: 47 ident: CR2 article-title: Childhood cancer survival in Europe 1999–2007: results of EUROCARE-5—a population-based study publication-title: Lancet Oncol doi: 10.1016/S1470-2045(13)70548-5 contributor: fullname: Clavel – volume: 24 start-page: 476 year: 2006 end-page: 83 ident: CR12 article-title: Risk of selected subsequent carcinomas in survivors of childhood cancer: a report from the Childhood Cancer Survivor Study publication-title: J Clin Oncol doi: 10.1200/JCO.2005.02.7235 contributor: fullname: Hammond – volume: 92 start-page: 709 year: 2000 end-page: 20 ident: CR31 article-title: Evidence for a causal association between human papillomavirus and a subset of head and neck cancers publication-title: J Natl Cancer Inst doi: 10.1093/jnci/92.9.709 contributor: fullname: Gillison – volume: 129 start-page: 106 year: 2003 end-page: 12 ident: CR36 article-title: High incidence of head and neck squamous cell carcinoma in patients with Fanconi anemia publication-title: Arch Otolaryngol Head Neck Surg doi: 10.1001/archotol.129.1.106 contributor: fullname: Huvos – ident: CR20 – volume: 49 start-page: 887 year: 2013 end-page: 92 ident: CR34 article-title: Inflammation in the context of oral cancer publication-title: Oral Oncol doi: 10.1016/j.oraloncology.2013.07.003 contributor: fullname: Lemmer – volume: 1 start-page: 29 year: 2009 ident: 2016_CR35 publication-title: Head Neck Oncol doi: 10.1186/1758-3284-1-29 contributor: fullname: AL Kruse – volume: 110 start-page: 649 year: 2018 ident: 2016_CR17 publication-title: J Natl Cancer Inst doi: 10.1093/jnci/djx235 contributor: fullname: CJ Bright – volume: 355 start-page: 1572 year: 2006 ident: 2016_CR4 publication-title: N Engl J Med doi: 10.1056/NEJMsa060185 contributor: fullname: KC Oeffinger – volume: 305 start-page: 2311 year: 2011 ident: 2016_CR5 publication-title: JAMA. doi: 10.1001/jama.2011.747 contributor: fullname: RC Reulen – ident: 2016_CR21 – volume: 4 start-page: 20 year: 2012 ident: 2016_CR28 publication-title: Head Neck Oncol doi: 10.1186/1758-3284-4-20 contributor: fullname: A Credé – volume: 192 start-page: 331 year: 2019 ident: 2016_CR26 publication-title: Radiat Res doi: 10.1667/RR15386.1 contributor: fullname: R Sakata – volume: 154 start-page: 316 year: 2021 ident: 2016_CR37 publication-title: Eur J Cancer doi: 10.1016/j.ejca.2021.06.004 contributor: fullname: RJ van Kalsbeek – volume: 15 start-page: 35 year: 2014 ident: 2016_CR2 publication-title: Lancet Oncol doi: 10.1016/S1470-2045(13)70548-5 contributor: fullname: G Gatta – volume: 80 start-page: 943 year: 1988 ident: 2016_CR25 publication-title: J Natl Cancer Inst doi: 10.1093/jnci/80.12.943 contributor: fullname: S Preston-Martin – volume: 92 start-page: 709 year: 2000 ident: 2016_CR31 publication-title: J Natl Cancer Inst doi: 10.1093/jnci/92.9.709 contributor: fullname: ML Gillison – volume: 2 start-page: 124 year: 2002 ident: 2016_CR9 publication-title: Nat Rev Cancer doi: 10.1038/nrc722 contributor: fullname: S Bhatia – volume: 82 start-page: 115 year: 2017 ident: 2016_CR13 publication-title: Eur J Cancer doi: 10.1016/j.ejca.2017.05.026 contributor: fullname: AA Hussein – volume: 129 start-page: 106 year: 2003 ident: 2016_CR36 publication-title: Arch Otolaryngol Head Neck Surg doi: 10.1001/archotol.129.1.106 contributor: fullname: DI Kutler – volume: 51 start-page: 55 year: 2015 ident: 2016_CR32 publication-title: Eur J Cancer doi: 10.1016/j.ejca.2014.10.016 contributor: fullname: A Näsman – ident: 2016_CR20 – ident: 2016_CR18 – volume: 103 start-page: 1457 year: 2005 ident: 2016_CR19 publication-title: Cancer. doi: 10.1002/cncr.20910 contributor: fullname: E Steliarova-Foucher – volume: 66 start-page: e27668 year: 2019 ident: 2016_CR7 publication-title: Pediatr Blood Cancer doi: 10.1002/pbc.27668 contributor: fullname: MM Fidler – volume: 149 start-page: 625 year: 1998 ident: 2016_CR27 publication-title: Radiat Res doi: 10.2307/3579909 contributor: fullname: AB Schneider – volume: 24 start-page: 476 year: 2006 ident: 2016_CR12 publication-title: J Clin Oncol doi: 10.1200/JCO.2005.02.7235 contributor: fullname: M Bassal – volume: 9 start-page: 29047 year: 2018 ident: 2016_CR33 publication-title: Oncotarget. doi: 10.18632/oncotarget.25540 contributor: fullname: C Goertzen – volume: 72 start-page: 98 year: 2017 ident: 2016_CR11 publication-title: Oral Oncol doi: 10.1016/j.oraloncology.2017.07.014 contributor: fullname: DH Moon – volume: 110 start-page: 183 year: 2018 ident: 2016_CR16 publication-title: J Natl Cancer Inst doi: 10.1093/jnci/djx165 contributor: fullname: MM Fidler – volume: 20 start-page: 531 year: 2019 ident: 2016_CR8 publication-title: Lancet Oncol doi: 10.1016/S1470-2045(18)30903-3 contributor: fullname: CJ Bright – volume: 103 start-page: 238 year: 2018 ident: 2016_CR3 publication-title: Eur J Cancer doi: 10.1016/j.ejca.2018.08.017 contributor: fullname: J Byrne – volume: 121 start-page: 2233 year: 2007 ident: 2016_CR14 publication-title: Int J Cancer doi: 10.1002/ijc.22827 contributor: fullname: PD Inskip – volume: 131 start-page: 738 year: 1999 ident: 2016_CR29 publication-title: Ann Intern Med doi: 10.7326/0003-4819-131-10-199911160-00004 contributor: fullname: HJ Kolb – ident: 2016_CR6 doi: 10.1136/gutjnl-2020-322237 – volume: 85 start-page: 776 year: 2013 ident: 2016_CR15 publication-title: Int J Radiat Oncol Biol Phys doi: 10.1016/j.ijrobp.2012.06.006 contributor: fullname: H Boukheris – volume: 22 start-page: 2009 year: 2014 ident: 2016_CR10 publication-title: Support Care Cancer doi: 10.1007/s00520-014-2260-x contributor: fullname: KE Effinger – volume: 33 start-page: 335 year: 2018 ident: 2016_CR1 publication-title: Eur J Epidemiol doi: 10.1007/s10654-018-0370-3 contributor: fullname: D Grabow – volume: 336 start-page: 897 year: 1997 ident: 2016_CR30 publication-title: N Engl J Med doi: 10.1056/NEJM199703273361301 contributor: fullname: RE Curtis – volume: 49 start-page: 887 year: 2013 ident: 2016_CR34 publication-title: Oral Oncol doi: 10.1016/j.oraloncology.2013.07.003 contributor: fullname: L Feller – volume: 100 start-page: 1068 year: 2008 ident: 2016_CR38 publication-title: J Natl Cancer Inst doi: 10.1093/jnci/djn210 contributor: fullname: C Frobisher – volume: 18 start-page: 695 year: 1999 ident: 2016_CR23 publication-title: Stat Med doi: 10.1002/(SICI)1097-0258(19990330)18:6<695::AID-SIM60>3.0.CO;2-O contributor: fullname: TA Gooley – volume: 79 start-page: 1465 year: 1997 ident: 2016_CR24 publication-title: Cancer. doi: 10.1002/(SICI)1097-0142(19970415)79:8<1465::AID-CNCR4>3.0.CO;2-A contributor: fullname: T Saku – volume: 51 start-page: 1131 year: 2015 ident: 2016_CR22 publication-title: Eur J Cancer doi: 10.1016/j.ejca.2014.01.027 contributor: fullname: E Steliarova-Foucher |
| SSID | ssj0009087 |
| Score | 2.4668822 |
| Snippet | Background
Survivors of childhood cancer are at risk of subsequent primary malignant neoplasms (SPNs), but the risk for rarer types of SPNs, such as oral... Survivors of childhood cancer are at risk of subsequent primary malignant neoplasms (SPNs), but the risk for rarer types of SPNs, such as oral cancer, is... Abstract Background Survivors of childhood cancer are at risk of subsequent primary malignant neoplasms (SPNs), but the risk for rarer types of SPNs, such as... BackgroundSurvivors of childhood cancer are at risk of subsequent primary malignant neoplasms (SPNs), but the risk for rarer types of SPNs, such as oral... Background: Survivors of childhood cancer are at risk of subsequent primary malignant neoplasms (SPNs), but the risk for rarer types of SPNs, such as oral... |
| SourceID | swepub pubmedcentral hal proquest crossref pubmed springer |
| SourceType | Open Access Repository Aggregation Database Index Database Publisher |
| StartPage | 80 |
| SubjectTerms | 631/67/2324 692/499 Adolescent Biomedical and Life Sciences Biomedicine Bone Neoplasms - complications Bone tumors Cancer Cancer and Oncology Cancer och onkologi Cancer Research Chemotherapy Children Clinical Medicine Drug Resistance Epidemiology Europe - epidemiology Exocrine glands Hodgkin Disease Hodgkin's lymphoma Humans Incidence Klinisk medicin Leukemia Leukemia - epidemiology Life Sciences Lymphoma Medical and Health Sciences Medicin och hälsovetenskap Molecular Medicine Mouth Neoplasms - epidemiology Mouth Neoplasms - etiology Neoplasia Neoplasms, Second Primary - epidemiology Neoplasms, Second Primary - etiology Oncology Oral cancer Pharynx Radiation therapy Risk Factors Salivary gland Sarcoma Survivors Teenagers Tongue |
| SummonAdditionalLinks | – databaseName: Public Health Database dbid: 8C1 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1baxQxFA62gvgi3p1aJYhvdmg2yWQSX6SULotYEbXQt5ArXSqz68xuS3-Hf9iTuew6FvoQGGYyEzLfyTlfTk5OEHoPcmIodSC8pLAwQSExByvHc26ZcyoAgfbJNXD6VczO-Ofz4rx3uDV9WOWgE1tF7Rcu-cgPKcy3kz0j6tPyd55OjUqrq_0RGjvo_gTsXJp8yeNtiIcissuZmdxxipJ-0wxh8rDhE6AieYplB8IEV9cjw7RzkcIib3PO26GTm_XT_3KNtvZp-hg96oklPuok4Qm6F6qn6MFpv3T-DP35Pm8u8SLiBlRFGz-9wssu1QROu_SxS_jXeF5hg9OxufUq1RbqgAuCi_wGhgS8C5rlalE36ZEbsiJjU0HZpIb650udr_8jBpaJv5kqbXb6sa6n6yVu09o-R2fTk5_Hs7w_kSF3RVmuclHyyAKX3lLnXVmUVKjIoyQxCKoi0BtgRz5aGVLUKrziJWM2OhoCkSYS9gLtVosqvELYl9wxGaiMjHHDjYXakTJrAqeGBJuhDwMcuv8bul0wZ1J34GkAT7fg6esMvQPENhVTzuzZ0Red7qWEYpQV4mqSof0BUN2P1EZv5SpDLztsN59hAhQUUNIMlSPUR-2Mn1TzizZHt5JARJXM0MEgH9sm7-rGSSdDoxZ-rZdQLBTdBC04MdRzo43npebeBq2ICTqIYIgnXBTK7N3d09foIQWu1nmS9tHuql6HN8CtVvZtO4D-AqlzIGE priority: 102 providerName: ProQuest – databaseName: Springer_OA刊 dbid: C6C link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1da9UwGA5ugngj87tuShDvXDFL0jTZ3TjscBAnog52F_LJDpOeQ9uzsd-xP7w3bc-ZdSJ4EShNmpf2eZM8Td48QegD-Imh1IHzksLCDwqJOYxyPOeWOacCEGifpgZOvorZKf98VpwNMjlpL8xo_Z7JTw0_AMqQp5hzIDZwdbWFHqYxOB3TMBGTO4FdInt9zDT1pigZNsj8vY7RILR1nkIg7_PL-2GSm7XSP3RFu7FouoOeDCQSH_WoP0UPQvUMPToZlsmfo5vv8-YCLyJuoFvoYqVbvOxlJXDakY9dwrrG8wobnI7IrdtUWqh9Lggu8mtwf3gWepHLRd2kLLdWQMamgrSRgfqtpn5e_xADo8TfTJU2Nv1Y1dPVEncSti_Q6fT452SWD6cv5K4oyzYXJY8scOktdd6VRUmFijxKEoOgKgKVARR8tDKkCFV4xEvGbHQ0BCJNJOwl2q4WVXiNsC-5YzJQGRnjhhsLpSNl1gRODQk2Qx_XcOjha-hucZxJ3YOnATzdgaevMvQeENsUTPrYs6MvOt1L4mGUFeLyIEN7a0D10CobTUuRgkIkURl61WO7qYYJ6IyAfmaoHKE-sjPOqebnnR63kkA6lczQ_to_7kz-6zWOex8aWfi1WkKykHQTtODEUM-NNp6XmnsbtCIm6CCCIZ5wUSjz5v_M7qLHFHhaP4u0h7bbehXeAq9q7buuQd0CSPMZ4A priority: 102 providerName: Springer Nature |
| Title | Risk of subsequent primary oral cancer in a cohort of 69,460 5-year survivors of childhood and adolescent cancer in Europe: the PanCareSurFup study |
| URI | https://link.springer.com/article/10.1038/s41416-022-02016-w https://www.ncbi.nlm.nih.gov/pubmed/36319851 https://www.proquest.com/docview/2761007809 https://hal.science/hal-04122356 https://pubmed.ncbi.nlm.nih.gov/PMC9814398 https://lup.lub.lu.se/record/640a2d4a-ad47-4dbe-90ae-e6ea0d04659a |
| Volume | 128 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1ba9swGBVNB6Uvo7t77YIYe1vdKJIsy3vrQkIYSwndCnkTkizR0NYJcdKy37E_vE--ZMsKe9iDjGPLVuzzyTqWjo4R-gBxoim1ELwkMfCCQnwMrRyPuWHWZg4IdB66BiYXYnzFv8yS2R5K2rkwlWjfmvlZcXt3VsyvK23l8s72Wp1YbzoZZBJa-Uz2OqgDAdq-ordOu0TWRpmhDy6jpJkpQ5jslbwP_CMOAnZgSbD2cIgOmIAolEl_p2HqXAdZ5GPO-Vg6uR0__ctrtGqfRkfoaUMs8Xl9Ac_Qniueo4NJM3T-Av28nJc3eOFxCY-KSj-9xsvaagKHWfrYBvxXeF5gjcNnc1frkFtkp1wQnMQ_oErAsfBkuV-syrDLtq7IWBeQttZQf5yp7uv_hIFl4qkuwmSnb5vVaLPEla3tS3Q1Gn4fjOPmiwyxTdJ0HYuUe-a4zA21uU2TlIrMcy-Jd4JmHugNsKPcG-mCahUOySVjxlvqHJHaE_YK7ReLwr1BOE-5ZdJR6RnjmmsDuT1lRjtONXEmQh9bOFRzN1Q1YM6kqnFUgKOqcFQPEXoPiG0zBs_s8flXFbYFQzHKEnHfj9BJC6hqamqpaCqCUESSLEKva2y3p2lDI0LpDuo75ezugZCtPLqbEI3QaRsfv4v812UM6xjaKeF2s4RkIKnSKcGJpjnXSuc8VTw3TmVEO-WE0yQnXCSZfvvff_gYHVKgcXUn0wnaX6827h3QrrXpQmWbpbCUg34XPfk8vJhewq-BGHSrCvgLDwst0w |
| link.rule.ids | 230,315,730,783,787,888,4033,12070,12237,21402,27937,27938,27939,31733,33280,33758,41134,42203,43324,43593,43819,51590,53806,53808,74081,74350,74638 |
| linkProvider | National Library of Medicine |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1db9MwFLXYkIAXxOcIDLAQbyyaZzuOwwua0KoC7YRgk_pm-VOrQGlJ0k38Dv4w10naEibtwVKUOLGSc319cn19jNBbsBNNqQXjJZmBHxQSUhjleMoNs7bwQKBdDA1MT8X4nH-eZbM-4Fb3aZVrn9g6arewMUZ-SOF_O45npPiw_JXGXaPi7Gq_hcYOuh11uKJ2fj7Lt6K7RHaamTEcV1DSL5ohTB7W_AioSBpz2YEwwdHVYGDauYhpkdc55_XUyc386X9ao-34NHqA7vfEEh93lvAQ3fLlI3Rn2k-dP0Z_vs3rH3gRcA2uos2fbvCyk5rAcZU-thH_Cs9LrHHcNrdqYm1RHHBBcJb-hi4B94JnuVxUdbxk16rIWJdQNtJQ_zypi_W_x8Ay8VddxsVO31fVaLXEraztE3Q-Ojn7OE77HRlSm-V5k4qcB-a5dIZaZ_Msp6IIPEgSvKBFAHoD7MgFI33MWoVbnGTMBEu9J1IHwp6i3XJR-mcIu5xbJj2VgTGuuTZQO1BmtOdUE28S9G4Nh-q_hmonzJlUHXgKwFMteOoqQW8AsU3FqJk9Pp6oeC4KilGWicujBO2vAVV9T63V1q4StNdhu3kME-CggJImKB-gPmhneKWcX7Qa3YUEIlrIBB2s7WPb5E2vcdLZ0KCFn6slFANF1V4JTjR1XCvteK64M14VRHvlhdfEES6yQj-_-U1fo7vjs-lETT6dfnmB7lHgbV1UaR_tNtXKvwSe1ZhXbWf6C6sTI4A |
| linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3fb9MwELZYJ028IH4vMMBCvLGonu04Di9oQKsCW1UNJu3NsmNbq0BpadJN_B38w5wTt6VM2oOlKLZjOXc-fz6fPyP0BvREU1qC8pLMwAKF-BRmOZ5yw8qycACgbXANnI7F6Jx_ucguYvxTHcMqVzaxNdR2VgYfeZ_CejvMZ6To-xgWMfk0fD__lYYbpMJOa7xOYwft5hy0qod2PwzGk7MNBS-RHYNmcM4VlMQjNITJfs2PAJikIbId4BM8XW9NUzuXIUjyJgK9GUi53k39j3m0na2G99G9CDPxcacXD9AdVz1Ee6dxI_0R-nM2rX_gmcc1GI42mrrB8454Aocz-7gM2rDA0wprHC7RXTShtCgOuSA4S3_DAIG6YGeuZos6ZJUrjmSsK0hroqh_vtR5_t9hwJx4oqtw9OnbcjFcznFLcvsYnQ8H3z-O0ng_Q1pmed6kIueeOS6toaUt8yynovDcS-KdoIUHsANYyXojXYhhhSpWMmZ8SZ0jUnvCnqBeNavcPsI25yWTjkrPGNdcGyjtKTPacaqJMwl6uxKHin9DtdvnTKpOeAqEp1rhqesEvQaJrQsGBu3R8YkK7wK9GGWZuDpK0MFKoCqO21pttCxBTzvZrj_DBJgrAKgJyrekvtXOdk41vWwZuwsJsLSQCTpc6cemydu6Meh0aKuFn8s5JANJ1U4JTjS1XCttea64NU4VRDvlhNPEEi6yQj-7vaev0B6MJHXyefz1ObpLAcR1LqYD1GsWS_cCQFdjXsbR9BeV3Ckj |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Risk+of+subsequent+primary+oral+cancer+in+a+cohort+of+69%2C460+5-year+survivors+of+childhood+and+adolescent+cancer+in+Europe%3A+the+PanCareSurFup+study&rft.jtitle=British+journal+of+cancer&rft.au=Sunguc%2C+Ceren&rft.au=Hawkins%2C+Michael+M&rft.au=Winter%2C+David+L&rft.au=Dudley%2C+Isabelle+M&rft.date=2023&rft.pub=Nature+Publishing+Group&rft.issn=0007-0920&rft.eissn=1532-1827&rft.volume=128&rft.issue=1&rft.spage=80&rft.epage=90&rft_id=info:doi/10.1038%2Fs41416-022-02016-w&rft.externalDBID=HAS_PDF_LINK |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0007-0920&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0007-0920&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0007-0920&client=summon |